Schistosoma mansoni Tegument Protein Sm29 Is Able to Induce a Th1-Type of Immune Response and Protection against Parasite Infection
2008

Sm29 Protein as a Vaccine Candidate Against Schistosomiasis

Sample size: 20 publication 10 minutes Evidence: moderate

Author Information

Author(s): Cardoso Fernanda C., Macedo Gilson C., Gava Elisandra, Kitten Gregory T., Mati Vitor L., de Melo Alan L., Caliari Marcelo V., Almeida Giulliana T., Venancio Thiago M., Verjovski-Almeida Sergio, Oliveira Sergio C.

Primary Institution: Universidade Federal de Minas Gerais, Brazil

Hypothesis

Can the Sm29 protein induce a protective immune response against Schistosoma mansoni infection?

Conclusion

The Sm29 surface protein is a promising vaccine candidate against schistosomiasis, showing significant protective effects in mice.

Supporting Evidence

  • Immunization with rSm29 resulted in a 51% reduction in adult worm burdens.
  • Vaccination led to a 60% reduction in intestinal egg counts.
  • High levels of specific anti-Sm29 IgG1 and IgG2a were produced in vaccinated mice.
  • Significant down-regulation of 495 genes in worms from vaccinated mice was observed.

Takeaway

Researchers found that a protein called Sm29 can help mice fight off a parasite that causes schistosomiasis, which is a disease affecting many people worldwide.

Methodology

Mice were immunized with recombinant Sm29 and then exposed to the parasite to assess protection levels.

Limitations

The study was conducted in a murine model, which may not fully replicate human responses.

Participant Demographics

C57BL/6 and TLR4 KO female mice, 6–8 weeks old.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pntd.0000308

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication